1
## **The Elizabeth Coteman Fund**
**Trustees’ Annual Report and Accounts Year ending March 2021**
## **Registered Charity Number 1171840**
2
## **Contents**
## **1. Reference and Administrative Details**
**2. Annual Report of the Trustees**
**3. Statement of Financial Activities**
## **1. Reference and Administrative Details**
3
The Trustees who served during the year ended 31 March 2021 were:
Emma Lane Gemma Coteman Gerald Coteman – acting Director (unpaid) Laura Coteman Mark Coteman
Administrator: Julie Moir (unpaid)
## **Registered Office:**
27 Thornton Court Cambridge CB3 0NS
## **Accountants:**
PG Associates William James House Cowley Road Cambridge CB4 0WX
## **Bank:**
The Co-operative Bank 1 Balloon Street Manchester M60 4EP
## **2. Annual Report of the Trustees**
## **Objectives:**
"The preservation and protection of good health for the public benefit and the relief of need among individuals, families and groups living with a diagnosis of pancreatic cancer or pancreatitis by:
4
- Offering grants to those groups working with individuals, families and groups living with a diagnosis of pancreatic cancer or pancreatitis.
- Offering grants to NHS clinical pancreatic cancer services where this will directly improve services and support for individuals and families living with a diagnosis of pancreatic cancer or pancreatitis - where funding would not otherwise be available.
- Supporting research into pancreatic cancer with selected grants for research teams and pancreatic cancer patients participating in clinical trials and promoting the publication of the useful results of that research.
- Raising awareness of pancreatic cancer and its effects.
- Providing financial, practical and emotional support to those diagnosed with pancreatic cancer and their families and carers through appropriate referral and signposting in a way that will improve quality of life.
- Working in partnership with other relevant charities and groups to achieve better outcomes for those diagnosed with pancreatic cancer and their families and carers".
## **Overview**
## Activity
This was a difficult year for people and families coping with a cancer diagnosis, with (NHS) care and treatment being less accessible and, therefore, less effective and supportive. The reluctance of many patients to push for further support meant that they experienced more anxiety and worse management of symptoms. From our point of view this resulted in fewer people seeking financial support and, therefore, our grant-making dipped a little both in terms of the number of grants made and the overall value of grant-making.
However, the advocacy, befriending and emotional support side of our work saw a heavy caseload, with referrals coming via the NHS (mostly from the Eastern Region), other charities, and from our website. The circumstances of lockdown and the pressures on the NHS made our work more urgent and more intense. Notwithstanding these challenges our work was instrumental in problem solving, supporting individuals and their families with information, practical help, emotional response, respite, and ‘hand-holding’. Satisfaction scores from those we have supported continues to be 100%. In spite of having to work differently (e.g., virtually for the most part) we have maintained a dynamic and effective service. Additionally, our work with the Cambridge Pancreatic Cancer Research Trials Programme has taken several steps forward in the cause of better patient and carer experience, all of which continues to satisfy our commitment (in our charitable objectives) to support research. Our (UK) geographical coverage continues to increase, and our reputation (as measured by feedback from patients, families and partners, and regular referrals) remains strong and is growing.
## Finance
Given the impact of Covid 19 on the charitable sector generally we had expected, and budgeted for, a lean income year. However, a large bequest from the estate of a patient we had supported for over three years, two other goodsized donations, and some fundraising by some of our most devoted supporters,
5
helped us to exceed our budget forecast by some way. The Charity has no salary or staff costs and strong reserves. In line with normal practice, the Charity will continue to monitor its forward financial plan and has a policy for reserves, which have grown again this year.
## **Governance**
The Trustees operate a light but robust model of governance to ensure that decisions relating to those we seek to support are made quickly and effectively – given the nature of pancreatic cancer this is essential if we are to continue to increase our impact. Relevant policies and procedures are in place, and followed, to ensure openness, accountability, data protection and relevant compliance. Trustees are also mindful of the Charity Commission’s public benefit test, which is adhered to.
## **Risk**
The Trustees have adopted a policy of low exposure to risk and have put in place a risk management framework that covers:
- Financial Risk
- Operational Risk
- Reputational Risk
- Compliance Risk
There are currently no major strategic risks to report. A foreseeable risk concerns the level of capacity available to manage day to day requirements, given the current reliance on volunteers. The Trustees will keep this issue under review. Trustees have a rolling objective to secure stable income and manage the Charity’s finances in a prudent manner.
## **Performance**
## Meeting Objectives (by comparison with previous year):
1. Grants to groups working with individuals, families and groups living with a diagnosis of pancreatic cancer or pancreatitis – **slightly lower.**
2. Grants to NHS clinical pancreatic cancer services where this will directly improve services and support for individuals and families living with a diagnosis of pancreatic cancer or pancreatitis, and where funding would not otherwise be available – **lower.**
**3.** Supporting pancreatic cancer research with selected grants for research teams and pancreatic cancer patients participating in clinical trials and publicising the useful results of that research – **no grants this year but such support tends to be given on a bi-annual basis.**
**4.** Raising awareness of pancreatic cancer and its effects – increased **–**
awareness raising, events, public presentations, and media coverage **maintained.**
5. Providing financial, practical, and emotional support to those diagnosed with pancreatic cancer and their families/carers through appropriate referral/signposting to improve quality of life – **numbers of cases maintained but with much higher levels of time input.**
6
**6.** Partnerships with other charities and groups to achieve better outcomes/quality of life for pancreatic cancer patients and their families – **our work with partners continues to increase.**
## Impact
The Trustees record and analyse feedback on services and support provided. Feedback forms are issued direct and via our partners although, given the nature of pancreatic cancer and its effect on families, it is sometimes difficult to encourage respondents to complete them. However, feedback received is, without exception, positive and values highly the support provided by the Charity. Examples are available on request.
## **3. Statement of Financial Activities**
## **The Elizabeth Coteman Fund Income and Expenditure for the Year Ended 31 March 2021**
|**Income**
**Period**
Donations - Personal
1,146.69
Donations - Corporate
333.00
Donations - Other
0.00
Interest on Investments
0.00
Other Income - Gift Aid
3.67
**Charitable Grants**
1,483.36
Charitable Expenditure - Grants
Payable
1,000.00
**Expenditure**
1,000.00
Cost of Fund Generation - Fund
Raising
0.00
0.00|**Year to**
**Date**
3,075.9
2
953.0
0
5,000.0
0
184.8
2
915.2
1
10,128.95
3,526.0
0
3,526.00
(396.0
0)
(396.00)|
|---|---|
7
|**Gross Surplus/(Loss):**
**Overheads**
Support Costs - Travelling Expenses
0.00
Support Costs - Printing and
Stationery
2.50
Support Costs - Telephone and
Computer Support Costs - General
Expenses
110.97
42.98
**Net Surplus/(Loss):**|483.36
6,998.95
78.0
0
89.1
0
218.
88
92.9
8
156.45
478.96
326.91
6,519.99|
|---|---|
## **The Elizabeth Coteman Fund Balance Sheet for the Year Ended 31 March 2021**
|**Fixed Assets**
**Current Assets**
Stock
Deposits and Cash
Bank Account
**Current Liabilities**
Creditors : Short Term|**Period**
0.00
0.00
0.00
326.91
326.91
0.00|**Year to**
**Date**
0.00
300.0
0
65,941.72
6,524.4
3
72,76
6.15
300.8
0|
|---|---|---|
8
|||0.00||300.8|
|---|---|---|---|---|
|||||0|
|**Current Assets less Current**||326.91||72,46|
|**Liabilities:**||||5.35|
|**Total Assets less Current**||326.91||72,46|
|**Liabilities:**||||5.35|
|**Long Term Liabilities**|||||
|||0.00||0.00|
|**Total Assets less Total Liabilities:**||326.91||72,46|
|**Capital & Reserves**||||5.35|
|Funds|0.00||65,945.36||
|I & E Account|326.91||||
||||6,519.9||
||||9||
|||326.91||72,46|
|||||5.35|
**The Elizabeth Coteman Fund CE010444 Receipts and payments accounts CC16a For the period 01-Apr-20 31-Mar-21 To from**
## **Section A Receipts and payments**
**----- Start of picture text -----**
Unrestricted Restricted Endowment
Total funds Last year
funds funds funds
to the nearest
to the nearest £ to the nearest £ to the nearest £ to the nearest £
£
A1 Receipts
Donations 9,029 - - 9,029 12,641
Grants - - - - 500
Fundraising - - - - 1,000
Transfer from CCF - - - - 16
Bank Interest Received 185 - - 185 -
Taxation reclaimed 915 - - 915 -
- - - - -
- - - - -
10,129 - - 10,129 14,157
Sub total (Gross income for AR)
A2 Asset and investment sales,
(see table).
- - - -
- - - - -
Sub total - - - - -
Total receipts 10,129 - - 10,129 14,157
A3 Payments
Grants 3,526 - - 3,526 9,015
Fund Raising Expenses - 396 - - - 396 500
PR and Marketing - - - - 210
Travelling, Subsistence and Entertaining 78 - - 78 1,750
Administration 308 - - 308 687
Sundry 93 - - 93 2,917
Bank Charges - - - - -
- - - - -
- - - - -
Sub total [ 3,609 ] - - 3,609 15,080
A4 Asset and investment
purchases, (see table)
- - - -
- - - -
Sub total [ - ] - - - -
Total payments 3,609 - - 3,609 15,080
Net of receipts/(payments) 6,520 - - 6,520 - 923
A5 Transfers between funds - - - - -
A6 Cash funds last year end 65,946 - - 65,946 66,383
Cash funds this year end 72,466 - - 72,466 65,460
**----- End of picture text -----**
CCXX R1 accounts (SS)
06/11/2021
1
## **Section B Statement of assets and liabilities at the end of the period**
|**Categories**
Signed by one or two trustees on behalf
of all the trustees
**B5 Liabilities**
**B3 Investment assets**
**B2 Other monetary assets**
**B4 Assets retained for the**
**charity’s own use**
**B1 Cash funds**|**Details**
**Details**
**Details**
**_Total cash funds_**
(agree balances with receipts and payments
account(s))
**Details**
Current Account
Deposit Account
**Details**
Signature|**Unrestricted**
**funds**
**Restricted**
**funds**
**to nearest £**
**to nearest £**
**6,524**
**-**
**65,942**
**-**
**-**
**-**
**72,466**
**-**
OK
OK
**Unrestricted**
**funds**
**Restricted**
**funds**
**to nearest £**
**to nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**Fund to which**
**asset belongs**
**Cost (optional)**
**-**
**-**
**-**
**-**
**-**
**Fund to which**
**asset belongs**
**Cost (optional)**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**Fund to which**
**liability relates**
**Amount due**
**(optional)**
**-**
**-**
**-**
**-**
**-**
Print Name|**Endowment**
**funds**
**to nearest £**
**-**
**-**
**-**|
|---|---|---|---|
||||**-**|
||||OK|
||||**Endowment**
**funds**
**to nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**Current value**
**(optional)**
**-**
**-**
**-**
**-**
**-**
**Current value**
**(optional)**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**When due**
**(optional)**
Date of
approval|
CCXX R2 accounts (SS)
06/11/2021
2